Designer Brands (DBI) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
31 Jan, 2026Executive summary
Q1 2024 net sales rose 0.6% to $746.6 million, with performance and leisure footwear outpacing the market and comparable sales down 2.5% year-over-year.
Gross profit margin improved by 80 basis points to 32.8%, driven by inventory management, DTC growth, and Brand Portfolio performance.
Adjusted net income was $4.8 million ($0.08 per diluted share); reported net income was $0.8 million ($0.01 per share), impacted by $4.0 million in after-tax restructuring and integration charges.
Strategic focus on athletic and casual categories, omni-channel enhancements, and cost optimization, with the Rubino acquisition expanding Canadian presence.
Full-year 2024 guidance reaffirmed, citing progress on strategic initiatives and operational efficiencies.
Financial highlights
Q1 net sales were $746.6 million, up 0.6% year-over-year; comparable sales down 2.5%.
Gross profit was $245.1 million, up from $237.7 million year-over-year.
Adjusted operating income was $14.7 million, down from $25.8 million last year.
Net income attributable to the company was $0.8 million, down from $11.4 million last year, with adjusted net income at $4.8 million.
Cash and cash equivalents were $43.4 million at quarter-end; total debt outstanding at $476.1 million.
Outlook and guidance
Reaffirmed 2024 guidance: low single-digit net sales growth and comparable sales up low single digits.
Adjusted diluted EPS expected in the $0.70–$0.80 range, up ~10% at midpoint vs. 2023, excluding potential charges.
Brands portfolio expected to grow mid-single digits, with double-digit DTC and wholesale growth.
Q3 projected as strongest sales period; Q4 expected to be weakest due to loss of 53rd week.
Capital costs for the year expected between $65 million–$75 million.
Latest events from Designer Brands
- Athleisure and kids' growth drove comps, but sales and outlook declined amid macro pressures.DBI
Q2 202521 Jan 2026 - Net sales fell 1.2%, gross margin declined, but adjusted operating income rose 40%.DBI
Q3 202511 Jan 2026 - Q4 saw a return to positive comps and 2025 guidance targets sales and EPS growth.DBI
Q4 202526 Dec 2025 - Gross margin and EPS surged, but sales fell; guidance expects further contraction.DBI
Q3 202611 Dec 2025 - Q4 saw a return to growth, with board elections, auditor ratification, and ESG progress on the agenda.DBI
Proxy Filing1 Dec 2025 - Definitive proxy materials filed for shareholder voting, no fee required.DBI
Proxy Filing1 Dec 2025 - Q1 2025 sales dropped 8% and net loss reached $17.4M as cost cuts and uncertainty persisted.DBI
Q1 202614 Nov 2025 - Net sales fell 4.2% and comps dropped 5% amid inflation, tariffs, and macroeconomic uncertainty.DBI
Q2 202611 Sep 2025